Combining two multiple sclerosis treatments has no clinical benefit, study findsBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1719 (Published 14 March 2013) Cite this as: BMJ 2013;346:f1719
- Lilian Anekwe
- 1BMJ Evidence Centre
Combining glatiramer and interferon beta in patients with relapsing-remitting multiple sclerosis does not reduce symptoms or disability over three years, when compared with either treatment alone, a study has found.
The study, which was funded by the US National Institutes of Health, looked at the effects …